welcome
ScienceDaily

ScienceDaily

Health

Health

Dual-action approach targeting inflammation shows potential as Type 1 diabetes treatment

ScienceDaily
Summary
Nutrition label

81% Informative

A new strategy may help prevent or slow the progression of Type 1 diabetes by targeting an inflammation-related protein known to drive the disease.

The research team hopes their findings will support future clinical trials to safely assess the efficacy of a new drug or drug combination in humans.

A medication that inhibits TYK2 is already approved for the treatment of psoriasis, an autoimmune condition that causes skin inflammation.

VR Score

89

Informative language

94

Neutral language

74

Article tone

formal

Language

English

Language complexity

76

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links